For the year ending 2025-12-31, NSPR had -$9,977K decrease in cash & cash equivalents over the period. -$36,765K in free cash flow.
| Cash Flow | 2025-12-31 |
|---|---|
| Net loss | -48,786 |
| Depreciation | 476 |
| Gain from sale of property, plant and equipment | 14 |
| Change in fair value of marketable securities, net of interest received | 359 |
| Change in liability for employees rights upon retirement | -20 |
| Other financial income | 133 |
| Change in operating right of use asset and operating leasing liability | -554 |
| Share-based compensation expenses | 12,332 |
| Gain on amounts funded in respect of employee rights upon retirement, net | 299 |
| Increase in prepaid expenses | 236 |
| Decrease (increase) in trade receivables | 596 |
| Decrease (increase) in other receivables | -282 |
| Increase in inventory | 826 |
| Increase in trade payables | 1 |
| Increase in other payables | 2,481 |
| Net cash used in operating activities | -35,103 |
| Purchase of property, plant and equipment | 1,662 |
| Proceeds from sale of property, plant and equipment | 15 |
| Investments in marketable securities | 56,840 |
| Proceeds from matured marketable securities | 27,648 |
| Amounts funded in respect of employee rights upon retirement | 91 |
| Amounts withdrawn in respect of employee rights upon retirement | 370 |
| Net cash provided by (used in) investing activities | -30,560 |
| Proceeds from exercise of warrants, net of 1,000 issuance costs | 16,855 |
| Proceeds from issuance of shares and pre-funded warrants, net of 3,148 and 81 issuance costs, respectively | 38,714 |
| Net cash provided by financing activities | 55,569 |
| Effect of exchange rate changes on cash and cash equivalents | 117 |
| Increase (decrease) in cash and cash equivalents | -9,977 |
| Balance of cash and cash equivalents at beginning of year | 18,916 |
| Balance of cash and cash equivalents at end of year | 8,939 |
InspireMD, Inc. (NSPR)
InspireMD, Inc. (NSPR)